Literature DB >> 11987433

The influence of methodologic quality on the conclusion of a landmark meta-analysis on thrombolytic therapy.

Arianne P Verhagen1, Henrica C W de Vet, Frank Vermeer, Jos W M G Widdershoven, Robert A de Bie, Alphons G H Kessels, Maarten Boers, Piet A van den Brandt.   

Abstract

OBJECTIVE: We studied the influence of the methodologic quality of individual trials on the outcome of a landmark meta-analysis on thrombolytic therapy in acute myocardial infarction. From each study we extracted the number of patients in both groups who died in hospital or during follow-up. Methodologic quality was assessed using the Delphi list. We first recalculated pooled odds ratios (ORs) and 95% confidence intervals (CIs), on the studies found and compared them with the original results of Yusuf et al. Next we incorporated the results of quality assessment in five different ways in the calculation of the pooled ORs: a) component analysis; b) visual plot; c) quality score as a threshold score; d) quality score as a weighting factor; and e) cumulative pooling. RESULTS AND
CONCLUSION: No correlation between quality scores and ORs was found. Studies with a proper description of the different quality components provided an estimate close to the true treatment effect. No major differences were found between the results of the five different methods of incorporating the quality scores into the final conclusion.

Entities:  

Mesh:

Year:  2002        PMID: 11987433

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  5 in total

Review 1.  The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis.

Authors:  Ingeborg M van Geijlswijk; Hubert P L M Korzilius; Marcel G Smits
Journal:  Sleep       Date:  2010-12       Impact factor: 5.849

Review 2.  Eccentric overload training in patients with chronic Achilles tendinopathy: a systematic review.

Authors:  J J Kingma; R de Knikker; H M Wittink; T Takken
Journal:  Br J Sports Med       Date:  2006-10-11       Impact factor: 13.800

Review 3.  Randomisation to protect against selection bias in healthcare trials.

Authors:  Jan Odgaard-Jensen; Gunn E Vist; Antje Timmer; Regina Kunz; Elie A Akl; Holger Schünemann; Matthias Briel; Alain J Nordmann; Silvia Pregno; Andrew D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

4.  Evaluating the role of quality assessment of primary studies in systematic reviews of cancer practice guidelines.

Authors:  Melissa C Brouwers; Mary E Johnston; Manya L Charette; Steve E Hanna; Alejandro R Jadad; George P Browman
Journal:  BMC Med Res Methodol       Date:  2005-02-16       Impact factor: 4.615

5.  Development and evaluation of a pedagogical tool to improve understanding of a quality checklist: a randomised controlled trial.

Authors:  Lola Fourcade; Isabelle Boutron; David Moher; Lucie Ronceray; Gabriel Baron; Philippe Ravaud
Journal:  PLoS Clin Trials       Date:  2007-05-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.